PlexusDx's microdose GLP-1 protocol, available at $129/mo, offers an alternative approach for those seeking slower titration to reduce acute GI disruption while still achieving therapeutic benefit
Wegovy and Ozempic are brand names for injectable prescription medications that contain semaglutide, and theyre targeted towards different conditions
These include but are not limited to muscle growth, fat metabolism, tissue repair, and overall vitality
Most participants tolerated the medication well, with the most common side effects being mild to moderate digestive issues such as nausea, vomiting, or diarrheaparticularly when first starting the medication or increasing the dosage
These applications include significantly reducing the incidence of obesity-related cancers such as colorectal and liver cancer, their use in neurodegenerative intervention therapies that can lower dementia risk by 45%, and the ability of semaglutide to slow the progression of kidney disease in diabetic patients while reducing kidney- and cardiovascular-related mortality